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RESEARCH ARTICLE

The effects of AICAR and rapamycin on mitochondrial
function in immortalized mitochondrial DNA mutator murine
embryonic fibroblasts

ABSTRACT

INTRODUCTION

Mitochondrial DNA mutations accumulate with age and may play a
role in stem cell aging as suggested by the premature aging
phenotype of mitochondrial DNA polymerase gamma (POLG)
exonuclease-deficient mice. Therefore, E1A immortalized murine
embryonic fibroblasts (MEFs) from POLG exonuclease-deficient
and wild-type (WT) mice were constructed. Surprisingly, when some
E1A immortalized MEF lines were cultured in pyruvate-containing
media they slowly became addicted to the pyruvate. The POLG
exonuclease-deficient MEFs were more sensitive to several
mitochondrial inhibitors and showed increased reactive oxygen
species (ROS) production under standard conditions. When cultured
in pyruvate-containing media, POLG exonuclease-deficient MEFs
showed decreased oxygen consumption compared to controls.
Increased AMP-activated protein kinase (AMPK) signaling and
decreased mammalian target of rapamycin (mTOR) signaling
delayed aging and influenced mitochondrial function. Therefore,
the effects of 5-aminoimidazole-4-carboxamide ribonucleotide
(AICAR), an AMPK activator, or rapamycin, an mTOR inhibitor, on
measures of mitochondrial function were determined. Rapamycin
treatment transiently increased respiration only in WT MEFs and,
under most conditions, increased ATP levels. Short term AICAR
treatment transiently increased ROS production and, under most
conditions, decreased ATP levels. Chronic AICAR treatment
decreased respiration and ROS production in WT MEFs. These
results demonstrate the context-dependent effects of AICAR and
rapamycin on mitochondrial function.

Several lines of evidence suggest the involvement of mitochondrial
dysfunction in the aging process (Dai et al., 2012; Park and Larsson,
2011; Prolla and Denu, 2014). With aging, most eukaryotic
organisms accumulate mitochondrial DNA (mtDNA) point
mutations and/or deletions (Kazachkova et al., 2013; Melov et al.,
1995; Yui et al., 2003). Evidence indicates that the mtDNA base
substitution mutations in aged cells are primarily caused by DNA
polymerase gamma (POLG) errors early in development that
clonally expand over the lifespan (Larsson, 2010). But the cause of
the mtDNA deletions present in aged cells is less clear. There is
evidence that oxidative stress contributes to mtDNA deletion
formation (Zsurka et al., 2018) and that selective replication of
deleted mtDNA molecules allows them to outcompete wild-type
(WT) mtDNA molecules in just a few years. This may occur
because mtDNA molecules with select mtDNA deletions elude
feedback inhibition of the coupled processes of mtDNA
transcription and replication (Kowald and Kirkwood, 2018). With
aging, mtDNA mutations build up to deleterious levels in individual
cells in specific tissue regions, such as muscle fibers (McKenzie
et al., 2002), neurons in the substantia nigra region of the brain
(Kraytsberg et al., 2006), or in stem cells such as those present in the
colonic crypts (McDonald et al., 2006). The mitochondrial
dysfunction that occurs in stem cells of POLG exonucleasedeficient (also called mtDNA mutator) mice is likely responsible for
many of the premature aging phenotypes that arise in this model
(Ahlqvist et al., 2012), although the stem cell alterations were
somewhat distinct from those that occur during normal mouse aging
(Norddahl et al., 2011). The mitochondrial dysfunction in stem cell
niches from mtDNA mutator mice is likely facilitated by a decline in
mitophagy in these cells (Li-Harms et al., 2015). Since endurance
exercise rescued the premature aging phenotype and oxidative
damage to mtDNA without substantially changing the mtDNA
mutation load in these mice, mitochondrial RNA polymerase
errors caused by oxidative damage to mtDNA is a potential
mechanism driving the premature aging phenotype (Safdar et al.,
2016a). Endurance exercise increases mitochondrial biogenesis
and mtDNA copy number, which may also be partly responsible
for protection (Jiang et al., 2017; Safdar et al., 2011).
If mtDNA mutations occurring in young-to-middle aged
organisms contribute to aging, then therapies that stimulate
mitochondrial turnover through increased mitophagy of organelles
with mutant mtDNA and increased biogenesis of organelles with
normal mtDNA throughout a lifespan may prove effective at
delaying this process. Two methods for inducing autophagy and
mitophagy are activation of the AMP-dependent protein kinase
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(AMPK) signaling pathway and inhibition of the mechanistic target
of rapamycin (mTOR) signaling pathway (Meley et al., 2006).
AMPK is one of the main metabolic sensors responding to
increases in ADP and AMP levels in the cell (Hardie, 2011; Steinberg
and Kemp, 2009). But AMPK can also be activated by Ca2+ signaling
(Hawley et al., 2005) or increased levels of the glycolytic intermediate
fructose 1,6-bisphosphate (Lin and Hardie, 2018). AMPK is a
conserved heterotrimer (αβγ) and overexpression of an alpha subunit
has been shown to extend the lifespan in Caenorhabditis elegans
(Apfeld et al., 2004). AMPK activates glucose uptake, glycolysis,
fatty acid uptake and fatty acid beta-oxidation, in addition to inhibiting
the biosynthesis of glycogen, fatty acids, sterols, triglycerides and
phospholipids (Hardie and Ashford, 2014). AMPK activation has
been shown to improve skeletal muscle energy metabolism, possibly
through stimulation of mitochondrial biogenesis, while decreasing the
phosphorylation and activity of mTOR to stimulate autophagy (Abbas
and Wink, 2010; Egan et al., 2011; Wang et al., 2010). There is an
aging-related decline in the ability to activate AMPK (Reznick et al.,
2007), which could contribute to the impaired mitochondrial electron
transport chain (ETC) function and impaired autophagy (Rajawat
et al., 2009) occurring in aged tissues.
mTOR is a kinase that forms two distinctive complexes, mTORC1
and mTORC2. mTORC1 activity is stimulated by increased oxygen
levels, amino acids, energy levels and nutrient availability to promote
increased metabolism and cell cycle progression (Halloran et al.,
2012; Laplante and Sabatini, 2012). mTORC1 activation leads to
increased protein synthesis, cell growth, cell proliferation and cell
motility and an inhibition of autophagy (Kim et al., 2011). mTORC1
activity is inhibited by nutrient stress such as calorie restriction (CR),
and is potently inhibited by the compound rapamycin (Laplante and
Sabatini, 2012), although long term rapamycin treatment also inhibits
mTORC2 function (Schreiber et al., 2015). Decreasing mTOR
activity with rapamycin has been shown to increase lifespan in mice
(Harrison et al., 2009).
Viral E1A immortalized mtDNA mutator and WT cell lines were
established for the experiments performed here to more easily study
how rapamycin and the AMPK activator AICAR affect cellular
energy metabolism in mitotic cells with decreased mitochondrial
ETC activity, since accumulating evidence suggests that
mitochondrial dysfunction in mitotic stem cells may play a role in
the aging process (Ahlqvist et al., 2012; Baines et al., 2014;
Wahlestedt et al., 2014). The effects of AICAR and rapamycin on
energy metabolism in cells, such as certain types of stem cells,
which primarily generate ATP by glycolysis instead of by oxidative
phosphorylation, is not well understood. Therefore, experiments
were performed to examine how varying glucose and pyruvate
levels in the culture media altered the effects of AICAR and
rapamycin on mitochondrial function and cellular ATP levels.
While characterizing the E1A immortalized WT and mtDNA
mutator cell lines we identified that the addition of pyruvate to the
culture medium stimulated colony formation and, upon long term
culture in the presence of pyruvate, the E1A immortalized cells
frequently became addicted to it.
RESULTS
E1A immortalized mtDNA mutator MEFs are more sensitive
to most mitochondrial inhibitors

To establish a new model to study mitotic cell mitochondrial
dysfunction, stable adenoviral E1A transfected mtDNA mutator and
WT MEF cell lines were generated. The rationale behind the use of
the E1A protein to immortalize the MEFs was to prevent the
mutation or decline in abundance of p53 (Savelyeva and
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Dobbelstein, 2011), which commonly occurs during spontaneous
transformation of MEFs. Proper p53 function may be important
for the identification of therapies that maintain or enhance
mitochondrial function with aging as p53 is required for
mitochondrial biogenesis (Matoba et al., 2006), the efficient
repair of mtDNA (Achanta et al., 2005; de Souza-Pinto et al., 2004)
and for full mitochondrial pyruvate dehydrogenase activity
(Contractor and Harris, 2012). The mtDNA mutator and WT cell
lines were then characterized for the ability to form colonies when
grown in the presence of increasing concentrations of mitochondrial
inhibitors or oxidants that decrease mitochondrial respiratory
function. These studies were performed in part to determine if
the new mtDNA mutator cell line retained the same relative
insensitivity to oxidative stressors as shown for the primary MEFs
(Trifunovic et al., 2005). The results showed that colony formation
of mtDNA mutator MEFs were more susceptible than WT MEFs to
the ETC complex IV inhibitor azide, the uncoupler FCCP, the
mitochondrial protein synthesis inhibitor chloramphenicol and the
DNA intercalating agent ethidium which, because of its positive
charge, accumulates in mitochondria. There was also a very strong
trend for increased sensitivity to the mitochondrial ETC complex I
inhibitor rotenone (P=0.053). No statistical difference in sensitivity
was found for treatment with the ETC complex III inhibitor
antimycin A, the mitochondrial F0F1-ATP synthase inhibitor
oligomycin, or the oxidants tert-butyl hydroperoxide or hydrogen
peroxide (Fig. 1A-I). There was also no statistical difference for the
prevention of colony formation between the two cell lines when the
ETC complex III inhibitor myxothiazol was added (data not shown).
E1A immortalized mtDNA mutator MEFs are not more
sensitive to nucleoside analogs

Some nucleoside analog antivirals such as azidothymidine (AZT;
a chain terminating nucleoside reverse transcriptase inhibitor
used to treat HIV), dideoxycytidine (ddC; a chain terminating
nucleoside reverse transcriptase inhibitor formerly used to treat
HIV) and fialuridine (FIAU; a non-chain terminating thymidine
analog that resulted in lethal hepatotoxicity in a clinical trial for the
treatment of hepatitis B) are suspected to cause mitochondrial
dysfunction by incorporation into mtDNA (Johnson et al., 2001).
Therefore, we tested the toxicity of several nucleoside drugs on
WT and mtDNA mutator MEFs. Results showed no significant
differences in sensitivity for the prevention of colony formation
following the administration of any of the nucleoside analogs
including AZT, ddC, FIAU, cytarabine (Ara-C; a non-chain
terminating deoxycytidine analog used in chemotherapy) or
bromodeoxyuridine (BrdU; a non-chain terminating thymidine
analog used experimentally) (Fig. S1), suggesting that the murine
POLG exonuclease domain does not play a major role in protecting
the cells from the toxicity of the tested nucleoside analogs.
Pyruvate supplementation reveals a difference in the
respiratory rates between E1A immortalized WT and mtDNA
mutator MEFs

Because of the known longevity-modulating effects of AMPK and
TOR signaling in model organisms and because of the known
ability of autophagy to protect mitochondrial function (Wu et al.,
2009), a thorough characterization of the effects of AICAR and
rapamycin treatment on mitochondrial function and cellular
energetics in E1A immortalized mtDNA mutator and WT MEF
cell lines was performed. In addition, it was determined if altering
the glucose or pyruvate levels in the media affected mitochondrial
function or the effects of AICAR and rapamycin on mitochondrial
2
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Fig. 1. Sensitivity of WT and
MtDNA mutator (POLGexo−)
MEFs to mitochondrial toxins.
Mitochondrial mutator MEFs were
more sensitive than WT MEFs to
inhibition of colony formation by
azide (P=0.025), ethidium bromide
(P=0.046), FCCP (P=0.002) and
chloramphenicol (P<0.001). A very
strong trend for a difference in
sensitivity was also found for
rotenone (P=0.053). Colony
counting assays were performed to
determine IC50 values for (A) azide,
(B) ethidium bromide (EtBr), (C) tertbutyl hydroperoxide, (D) rotenone,
(E) antimycin A, (F) hydrogen
peroxide (H2O2), (G) FCCP, (H)
oligomycin, and (I) chloramphenicol.
Experiments were performed with
three independently derived E1A
immortalized WT and mtDNA
mutator clone lines (n=3).
Bars represent mean±s.e.m.
Unpaired t-tests were performed with
* indicating a P-value of <0.05 and
** indicating a P-value <0.001.

Ten or twenty day AICAR treatment decreases the
respiratory rate in WT MEFs

Although treatment with the AMPK activator AICAR has
been described to increase mitochondrial biogenesis in rodents
(Komen and Thorburn, 2014) and human fibroblasts (Golubitzky
et al., 2011), we, like others studying mitochondrial function in
hepatocytes (Guigas et al., 2007), myocytes (Spangenburg et al.,
2013), white adipocytes (Abdul-Rahman et al., 2016) or human
fibroblasts (Golubitzky et al., 2011), did not find a significant
increase in the respiratory rate following AICAR treatment.
This was true using either WT or mtDNA mutator MEFs
irrespective of glucose or pyruvate levels in the media or the
duration of treatment (Fig. 2A-D). However, we did find that
AICAR treatment of WT MEFs for 10 or 20 days cultured in
HGPUM led to a strong decrease in respiratory rate (Fig. 2E).
Rapamycin transiently increases the respiratory rate in WT
but not mtDNA mutator MEFs

Rapamycin treatment increased the respiratory rate in WT MEFs
after 24 h (Fig. 2A,C) but not after 48 h (Fig. 2B,D) of treatment
when cultured in HGM or LGPM. Treatment also did not affect the
respiratory rate after 10 (Fig. 2E), 20 (Fig. 2F) or 29 days (Fig. S2)
of treatment when cells were cultured in HGPUM. Rapamycin did
not significantly increase the respiratory rate under any of these
conditions in mtDNA mutator MEFs.
Reactive oxygen species production increases in mtDNA
mutator MEFs in HGM, but decreases following long
term culture in HGPUM

These studies were performed in part to determine if the E1A
immortalized mtDNA mutator MEFs retained the phenotype of the
parental primary MEFs of not increasing reactive oxygen species
(ROS) production when cultured in standard HGM (Trifunovic
3
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function. To accomplish this task, the immortalized MEFs were
cultured in either low (5 mM) glucose media in the presence of
1 mM pyruvate (LGPM), a media that stimulates mitochondrial
respiratory function (Weber et al., 2002); in high glucose medium
(HGM) (25 mM glucose) that lacks pyruvate; or, for long term
experiments in high glucose, pyruvate and uridine-containing
medium (HGPUM), a medium where cells can grow in the absence
of functional mtDNA (King and Attardi, 1989).
When cultured in HGM, in contrast to results found with primary
MEFs (Trifunovic et al., 2005), no significant difference in the
respiratory rates between E1A immortalized WT and mtDNA
mutator MEFs was found (Fig. 2A,B). This also greatly contrasts
with results using spontaneously transformed MEFs, where mtDNA
mutator MEFs were described to respire at only 5% of the rate of
WT MEFs (Kukat et al., 2011). However, more than a twofold
decline in the respiratory rate was revealed in E1A immortalized
mtDNA mutator MEFs when they were switched from HGM to
LGPM, while E1A immortalized WT MEFs did not show a
significant difference in respiratory rate when cultured in these two
types of media. Specifically, mtDNA mutator MEFs showed
deficits in respiratory rate after 24 (Fig. 2C) or 30 h (Fig. 2D) of
culture in LGPM or after 10 (Fig. 2E), 20 (Fig. 2F) or 29 days
(Fig. S2) of culture in HGPUM. There was a slight increase in
respiratory rate between the 10 and 20 day time points for WT
MEFs cultured in HGPUM, perhaps due to a delayed metabolic
adaptation to the pyruvate or uridine present in the culture media.
When cultured in HGPUM the mtDNA mutator MEFs showed a
greatly decreased respiratory rate on day 10 of culture, the first time
point taken, when compared to the rates in HGM. The respiratory
rate did not further decline for the next 19 days of culture suggesting
that if mtDNA mutations are accumulating when the MEFs are
grown in HGPUM, they accumulate quickly and reach a steady state
by day 10 of culture.

Biology Open (2018) 7, bio033852. doi:10.1242/bio.033852

Fig. 2. See next page for legend.

et al., 2005). When cultured in a low glucose medium (LGM) or
LGPM, depending upon the duration of treatment and the presence
of pyruvate, mtDNA mutator MEFs showed small trends for or

small significant increases in ROS production compared to WT
MEFs (Fig. 3A-D). In contrast to past results using primary MEFs,
large increases in ROS production were observed in the E1A
4
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Fig. 2. O2 consumption rates of WT and POLGexo− MEFs treated with
AICAR or rapamycin. (A) O2 consumption rates after 24 h in HGM. (B) O2
consumption rates after 48 h in HGM. (C) O2 consumption rates after 24 h in
LGPM. (D) O2 consumption rates after 30 h in LGPM. (E) O2 consumption
rates after 10 days in HGPUM. (F) O2 consumption rates after 20 days in
HGPUM. Rapamycin transiently increases oxygen consumption in WT
MEFs at the 24 h time point either in the absence or presence of pyruvate.
Respiratory deficits in POLGexo− MEFs were revealed by the LGPM used in
panels C and D and the HGPUM used in panels E and F. Experiments were
repeated twice using three technical replicates each time. Bars represent
mean±s.e.m. Two-way ANOVA with Fisher’s LSD post hoc analysis was
performed. *P<0.05, **P<0.001.

immortalized mtDNA mutator MEFs when they were cultured in
standard HGM. The ROS levels declined substantially when
the MEFs were cultured in HGPM where pyruvate was present
(Fig. 4A-D). In contrast to the results from these short term culture
studies, culture for 10 days in HGPUM led to decreased ROS
production in mtDNA mutator MEFs compared to WT MEFs
(Fig. 4E,F), likely due to the much lower ETC activity present

Biology Open (2018) 7, bio033852. doi:10.1242/bio.033852

in mtDNA mutator MEFs compared to WT MEFs under these
pyruvate-containing culture conditions as indicated by the
respiratory studies. Decreased ETC activity can decrease ROS
production when greatly decreased numbers of electrons enter and
are passed down the ETC, leading to fewer electrons bound by O2 to
form superoxide.
AICAR treatment for 48 h increases, but for 10 days
decreases, ROS production

Treatment with AICAR for 24 h had little to no effect on ROS
production depending upon the exact glucose and pyruvate
levels present (Figs 3A,C and 4A,C). However, treatment with
AICAR for 48 h almost invariably increased ROS production in
both mtDNA mutator and WT MEFs (Figs 3B,D and 4B,D)
irrespective of glucose and pyruvate levels. However, after 10 or
20 days of AICAR treatment in HGPUM (Fig. 4E,F), ROS levels
were decreased, likely reflecting the lower respiratory rate induced
by AICAR at these time points likely as a result of the mechanism
described above.

Biology Open
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Fig. 3. Effects of AICAR or rapamycin on ROS production of WT and POLGexo− MEFs under low glucose conditions. Rapamycin treatment in
LGM or LGPM had no effect on ROS production. 0.5% ethanol (EtOH) was added as a positive control to induce ROS production. (A) ROS levels after 24 h in
LGM. (B) ROS levels after 48 h in LGM. (C) ROS levels after 24 h in LGPM. (D) ROS levels after 48 h in LGPM. Experiments were repeated twice using five
technical replicates each time. Bars represent mean±s.e.m. Two-way ANOVA with Fisher’s LSD post hoc analysis was performed. *P<0.05, **P<0.001.
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Fig. 4. See next page for legend.
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Fig. 4. Effects of AICAR or rapamycin on ROS production of WT and
POLGexo− MEFs under high glucose conditions. 0.5% ethanol (EtOH)
was added as a positive control to induce ROS production. (A) ROS levels
after 24 h in HGM. (B) ROS levels after 48 h in HGM. (C) ROS levels after
24 h in HGPM. (D) ROS levels after 48 h in HGPM. (E) ROS levels after
10 days in HGPUM. (F) ROS levels after 20 days in HGPUM. Experiments
were repeated twice using five technical replicates each time. Bars represent
mean±s.e.m. Two-way ANOVA with Fisher’s LSD post hoc analysis was
performed. *P<0.05, **P<0.001.

Rapamycin treatment does not affect the rate of ROS
production in WT or mtDNA mutator MEFs

Under almost every culture condition tested, rapamycin treatment
had no significant effect on ROS production (Figs 3A-D and 4A-F).
The only exception to this was a very small decrease in ROS
production in mtDNA mutator MEFs after 24 h of treatment in
HGM (Fig. 4A).

Biology Open (2018) 7, bio033852. doi:10.1242/bio.033852

MtDNA mutator MEFs generally show decreased ATP levels
in LGM, but increased ATP levels in HGM

We next monitored ATP levels in the mtDNA mutator and WT
MEFs. As expected from the results of the respiratory studies, when
cultured in LGM or LGPM (Fig. 5A-D), mtDNA mutator MEFs
generally showed decreased ATP levels. ATP levels in the mtDNA
mutator MEFs dropped significantly between the 24 and 48 h time
points as the cells gradually failed to maintain cellular energy levels
under the low glucose conditions. But, ATP levels were generally
increased in mtDNA mutator MEFs compared with WT MEFs
when were they were cultured in HGM, HGPM or HGPUM
(Fig. 6A-E). Therefore, there is likely a compensatory upregulation
of glycolysis in the mtDNA mutator MEFs that leads to increased
ATP levels in the presence of high glucose. To verify this, we
measured the rate of acidification of fresh media on confluent
cultures grown in HGM. This method is an indirect measure of the
rate of glycolysis because the glycolytic end product pyruvate can
be reduced to lactate and excreted from cells to acidify the media. As
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Fig. 5. Effects of AICAR or rapamycin on ATP levels of WT and POLGexo− MEFs under low glucose conditions. (A) ATP levels after 24 h in LGM.
(B) ATP levels after 48 h in LGM. (C) ATP levels after 24 h in LGPM. (D) ATP levels after 48 h in LGPM. Experiments were repeated twice using five
technical replicates each time. Bars represent mean±s.e.m. Two-way ANOVA with Fisher’s LSD post hoc analysis was performed. *P<0.05, **P<0.001.
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Fig. 6. See next page for legend.
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Fig. 6. Effects of AICAR or rapamycin on ATP levels of WT and
POLGexo− MEFs under high glucose conditions. (A) ATP levels after
24 h in HGM. (B) ATP levels after 48 h in HGM. (C) ATP levels after 24 h in
HGPM. (D) ATP levels after 48 h in HGPM. (E) ATP levels after 10 days in
HGPUM. (F) ATP levels after 20 days in HGPUM. Experiments were
repeated twice using five technical replicates each time. Bars represent
mean±s.e.m. Two-way ANOVA with Fisher’s LSD post hoc analysis was
performed. **P<0.001.

expected, a confluent monolayer of mtDNA mutator MEFs acidified
the medium much more rapidly than WT MEFs, with their medium
pH being 6.92±0.10 after 48 h and 6.05±0.02 after 72 h, while the
WT MEFs’ medium pH was 7.24±0.04 after 48 h and 6.84±0.05
after 72 h.
AICAR treatment decreases ATP levels under
most conditions

We next performed experiments treating the WT and mtDNA
mutator MEFs with AICAR and measuring cellular ATP levels.
When using low glucose culture media, AICAR administration
generally decreased ATP levels in WT MEFs and following the 24 h
treatment in mtDNA mutator MEFs. But AICAR treatment
stabilized ATP levels to completely prevent the drop in ATP
levels between the 24 and 48 h time points of the mtDNA mutator
MEFs in LGPM (Fig. 5A-D). When cells were cultured in HGM and
HGPM, AICAR treatment consistently decreased ATP levels
(Fig. 6A-D). This was also true for the 10 and 20 day treatments
of mtDNA mutator MEFs in HGPUM (Fig. 6E,F). But in contrast to
this, WT MEFs cultured with AICAR for 10 days in HGPUM
showed increased ATP levels (Fig. 6E), but this increase dissipated
by 20 days of treatment (Fig. 6F).
Rapamycin increases ATP levels following 48 h of treatment
in LGM

When cultured in LGM or LGPM, rapamycin treatment for 24 h
(Fig. 5A,C) generally had no significant effect on ATP levels, with
one exception. In contrast, when MEFs were cultured for 48 h in
LGM or LGPM, rapamycin treatment led to a consistent increase in
ATP levels (Fig. 5B,D). When cultured in HGM or HGPM
(Fig. 6A-D), the MEFs generally showed a quicker, but greatly
blunted response to the rapamycin treatment, especially the
mtDNA mutator MEFs, which only showed increased ATP levels
at the 24 h time point when cultured in HGM. The WT MEFs
showed small increases in ATP levels with rapamycin treatment
under all HGM and HGPM culture conditions, as well as at the
10 day time point in HGPUM (Fig. 6E), but this dissipated by
20 days of treatment (Fig. 6F).
Long term culture of E1A immortalized MEFs in pyruvatecontaining media can induce pyruvate addiction

Cell lines with depleted or highly mutated mtDNA can only grow in
an HGM with the supplementation of pyruvate and uridine to the
culture medium (King and Attardi, 1989). We hypothesized that the
immortalized mtDNA mutator MEFs could only accumulate a small
amount of mtDNA mutations before cell death when cultured in
normal HGM because of the cell’s reliance on mitochondrial
function under this condition, but a higher level of mitochondrial
ETC dysfunction may be revealed if the MEFs were cultured in
HGM with pyruvate and uridine (HGPUM) that is permissive for
the loss of mtDNA. Results showed that under basal conditions both
mtDNA mutator and WT E1A immortalized MEFs formed an
average of approximately 30% more colonies when cultured in
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HGPUM compared to HGM depending upon the specific clonal cell
line tested (See day 0 data in Fig. S3). Therefore, the E1A
immortalization process appeared to be altering metabolism so
that a slight toxicity is induced under the standard HGM culture
conditions that was rescued by the presence of pyruvate or uridine in
the medium. We next cultured the clonal lines of MEFs for
2-3 months in HGPUM and roughly every 10 days seeded cells into
wells on plates containing HGM to determine the number of
colonies formed. One E1A immortalized mtDNA mutator MEF line
slowly lost the ability to form colonies when placed in HGM over
2 months of culture in HGPUM, while two others did not.
Surprisingly, one of three E1A-transfromed WT MEF lines also
showed a decreased ability over time to form colonies when taken
from HGPUM and seeded into HGM. We also found this slow loss
of colony formation to occur when uridine was absent from the
media, but not when pyruvate was absent (data not shown), so the
decreased rate of colony formation was independent of mtDNA
mutations. We decided to call this phenomenon ‘pyruvate
addiction’ due to the previously established nomenclature of
‘glucose addiction’ and ‘glutamine addiction’ when describing
cancer cells.
In contrast to the results using E1A immortalized MEFs,
spontaneously transformed mtDNA mutator cell lines formed
colonies equally well in HGPUM and HGM under basal conditions
and none of the three spontaneously transformed mtDNA mutator
cell lines lost the ability to form colonies in HGM after being cultured
for 2 months in HGPUM. Data from one spontaneously transformed
clone is shown in Fig. S3. These data suggest that the pyruvate
addiction is likely a result of the E1A-based immortalization process.
To learn more about the pyruvate addiction phenotype of the E1A
immortalized MEFs, the same types of long term culture
experiments were performed as before, but this time the mtDNA
mutator MEF line, which previously showed the progressive
pyruvate addiction phenotype, was supplemented with compounds
known to protect mitochondria or stimulate mitochondrial
biogenesis. The cells were then assayed for the ability to form
colonies in HGM without the added compound. As shown in
Fig. S4, AICAR treatment delayed the pyruvate addiction
phenotype, while rosiglitazone, metformin, nicotinamide, resveratrol
or a high (50 mM) pyruvate concentration did not. Treatment with
a high pyruvate concentration has previously been shown to
induce mitochondrial biogenesis (Wilson et al., 2007). AICAR
and more specific AMPK activators are known to either increase or
decrease the rate of autophagy depending upon the specific cell
type studied (Lee et al., 2010; Samari and Seglen, 1998).
In many cases, the rate of autophagy has been reported to
positively correlate with organismal lifespan (Hansen et al., 2008;
Melendez et al., 2003). Therefore, the effects of two autophagy
inducers on pyruvate addiction were tested. Opposite to the results
with AICAR treatment, the addition of rapamycin (Fig. S4) or a low
5 mM dose of ammonium chloride (Fig. S5), a concentration that
induces autophagy in MEFs (Cheong et al., 2011), greatly
stimulated the onset rate of pyruvate addiction. Higher than 10 or
20 mM doses of ammonium chloride – doses that inhibit autophagy
in MEFs (Cheong et al., 2011) – were toxic, suggesting that
autophagy may be needed for long term survival of the E1A
immortalized MEFs. One of the rapamycin-treated pyruvateaddicted clonal cell lines slowly lost the pyruvate addiction
phenotype after 2 months in culture and regained the ability to
form colonies when cultured in HGM that lacks pyruvate (Fig. S4)
demonstrating that pyruvate addiction is a reversible event in a
cell population. When E1A immortalized WT MEFs instead of
9
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mtDNA mutator MEFs were used and similar results were obtained
with rapamycin or 5 mM ammonium chloride addition greatly
stimulating pyruvate addiction (Fig. S5).
Since the three autophagy modulators above affected the rate of
pyruvate addiction, similar long term experiments were performed
supplementing the media with three autophagy inhibitors including 3methyladenine (a class III PI3K inhibitor), bafilomycin A1 (a vacuolar
H+ ATPase inhibitor), or chloroquine (a weak base that decreases
lysosomal acidity) (Fig. S5). Due to the toxicity of the compounds,
concentrations were titrated down from those used in acute studies of
autophagy inhibition to allow for long term cell viability (see
Materials and Methods for more details). Both 3-methyladenine and
bafilomycin A1 affected pyruvate addiction, but the results varied
depending upon the specific clonal cell line used, while chloroquine,
like AICAR, consistently delayed pyruvate addiction, although to a
lesser extent. This data combined with the results from rapamycin and
ammonium chloride treatment suggest that autophagy inducers
stimulate pyruvate addiction and autophagy inhibitors generally had
the opposite effect of delaying pyruvate addiction, although
inconsistent results were obtained due to the sub-optimal doses that
had to be used to prevent long term toxicity.
Since pyruvate addition increased colony formation in E1A
immortalized MEFs in the absence of any added stressor,
we hypothesized it would also protect these MEFs against
mitochondrial toxins. The addition of pyruvate to the HGM
medium (to make HGPM) remarkably increased the IC50 of colony
formation of mtDNA mutator MEFs in the presence of the complex
I inhibitor rotenone from approximately 4 nM to 120 nM (Fig.
S6A). The addition of pyruvate also increased the IC50 of mtDNA
mutator MEFs in the presence of ethidium bromide from roughly
70 ng/ml to 150 ng/ml (Fig. S6B), only a modest increase compared
to the IC50 of 375 ng/ml measured using WT MEFs in HGM.
DISCUSSION

In this report it is shown that E1A immortalized mtDNA mutator
MEFs can be used as a mitotic cell model to study physiological
levels of mitochondrial ETC dysfunction, unlike the nonphysiological ETC dysfunction observed in primary MEFs from
this premature aging model (Trifunovic et al., 2005). The
metabolic effects of potential anti-aging protein kinase
modulators and altered levels of energy substrates in the culture
media were studied. It was found that AICAR or rapamycin had
variable effects on energy metabolism depending upon the culture
conditions present, and so therefore, these kinases likely respond
to the cellular nutrient availability when regulating energy
metabolism. The data produced in this study is complementary
to that produced in a study that showed AICAR treatment had
greatly different effects on viability, cell growth, mitochondrial
biogenesis, ROS production, and mitochondrial membrane
potential depending upon the cell line used, with roughly equal
numbers of cell lines showing increased or decreased
mitochondrial biogenesis and membrane potential following
AICAR treatment (Jose et al., 2011).
Mitochondrial inhibitor sensitivity of WT and mtDNA
mutator MEFs

MtDNA mutator MEFs were more susceptible to growth inhibition
and toxicity caused by the presence of the mitochondrial toxins FCCP,
ethidium, chloramphenicol and azide, but not to the mitochondrial
inhibitors antimycin A or oligomycin, or to the oxidizing agents
hydrogen peroxide or tert-butyl hydroperoxide. There was also a large
trend for increased sensitivity with rotenone. It is not entirely clear
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why the mtDNA mutator MEFs appeared to be more sensitive than
WT MEFs to complex I and complex IV inhibitors, but not to complex
III or complex V inhibitors, but it is likely due to the fewer number of
genes present in mtDNA that compose complexes III and
V. Mammalian mtDNA only encodes one gene for complex III and
two genes for complex V, while mtDNA encodes three genes for
complex IV and seven genes for complex I. The greater number and
size of the genes present in mtDNA increases the likelihood that the
genes will be disrupted by mutation in mtDNA mutator cells to
sensitize the cells to the toxic effects of the specific ETC complex
inhibitors. This rationale also likely explains why the mtDNA
mutator MEFs were more sensitive to the mitochondrial protein
synthesis inhibitor chloramphenicol, as mitochondrial ribosomal
function requires the two large ribosomal RNAs as well as 22
small tRNAs encoded in the mtDNA. Greater apparent
susceptibility of mtDNA mutator MEFs to ETC complex I and
complex IV inhibitors suggests that complex I and complex IV
deficits in the immortalized MEFs are causes for the decreased
respiratory rate compared to WT MEFs that occurs when the
mtDNA mutator MEFs are cultured in the pyruvate-containing
medium. Complex I and complex IV deficits are the primary ETC
deficits that occur during aging (Navarro and Boveris, 2007)
further highlighting the utility of these cells as an aging model.
The data showing no difference in the toxicity of nucleoside
analogs between WT and mtDNA mutator MEFs is consistent with
the very slow removal of chain-terminating AZT monophosphate
and ddC monophosphate from the end of a DNA strand by the
human POLG exonuclease site (Johnson et al., 2001). Although
FIAU monophosphate was shown to be a good substrate for POLG
exonuclease activity (Johnson et al., 2001), murine mtDNA mutator
MEFs did not show increased sensitivity to FIAU toxicity. It is
known that FIAU causes liver mitochondrial toxicity in humans, but
not in mice (Xu et al., 2014) and this is likely due to a nucleoside
transporter targeted to human mitochondria that lacks the
mitochondrial targeting signal in mice (Lee et al., 2006).
Therefore FIAU may not be efficiently imported into murine
mitochondria to affect mitochondrial DNA synthesis.
E1A immortalized mtDNA mutator MEFs are a novel model
to identify therapies for aging-induced mitochondrial
dysfunction

E1A immortalized mtDNA mutator MEFs did not show significant
mitochondrial respiratory dysfunction in standard HGM culture
conditions, but did show respiratory dysfunction compared to WT
MEFs when pyruvate was present in the culture medium. However,
the E1A immortalized mtDNA mutator MEFs did show increased
ROS production under these standard conditions. Both of these
phenotypes differ from the results obtained in previous studies of
spontaneously transformed mtDNA mutator MEFs where very large
declines in respiratory activities occurred under these standard
conditions with no increased ROS production (Kukat et al., 2011;
Trifunovic et al., 2005). These differences appear to be due to the
viral E1A protein used to induce cell immortalization. The
exaggerated loss of mitochondrial respiratory function in the
primary and spontaneously transformed mtDNA mutator MEFs
(Trifunovic et al., 2005) does not replicate the small loss of
mitochondrial function commonly observed in aged cells
(Beckervordersandforth et al., 2017; Navarro and Boveris, 2007).
In addition, the increased ROS production in the E1A immortalized
mtDNA mutator MEFs under standard HGM culture conditions
make them a desirable cell line for screening for antioxidants, as
ROS production increases in most human tissues with age (Navarro
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and Boveris, 2007) and in almost all aging-related disorders (Gruber
et al., 2013). In contrast to the short term studies using HGM, after
10 days of culture in HGPUM mtDNA mutator MEFs showed a
decreased respiratory rate and ROS production. Since ROS
production can be a signal for mitochondrial biogenesis, these
results may explain the decreased levels of mtDNA present in some
tissues of mtDNA mutator mice (Safdar et al., 2011).
In rat fibroblasts, expression of the E1A protein was shown to
increase mitochondrial gene expression without altering mtDNA
levels (Glaichenhaus et al., 1986). This likely occurs through E1Amediated stabilization of the c-myc transcriptional regulator leading
to increased expression of mitochondrial transcription factor A
(TFAM) (Chakraborty and Tansey, 2009; Li et al., 2005). The E1A
protein is a well-established modulator of the Rb and p53 signaling
pathways involved in cellular senescence and apoptosis (Savelyeva
and Dobbelstein, 2011), which are activated by Ras signaling (de
Groof et al., 2009). In this way, E1A cooperates with activating Ras
mutations, such as H-RasV12, in stimulating cell transformation
(Seger et al., 2002). In human diploid fibroblasts Ras signaling
increased mitochondrial biogenesis and ROS production, which
was blocked by the E1A protein (Moiseeva et al., 2009). However,
in murine cells such as MEFs, E1A expression did not block
Ras-induced mitochondrial biogenesis and Drp1-mediated
mitochondrial fission (Serasinghe et al., 2015). In H-RasV12 and
E1A transformed MEFs the increased mitochondrial function that
occurs following immortalization was lost after around 20 cell
passages as Warburg (glycolytic) metabolism was selected (de
Groof et al., 2009). The strong Warburg effect in E1A immortalized
MEFs likely explains why there is little difference in respiratory
rates between the WT and mtDNA mutator genotypes in our study.
This high rate of glycolytic function in this model makes these E1A
immortalized MEFs a suitable metabolic model of aging in human
somatic stem cells that are also mostly glycolytic in energy
metabolism (Snoeck, 2015). In contrast, primary MEFs show a
more oxidative metabolism.
Moderate mitochondrial dysfunction was found in postmitotic
tissues from the mtDNA mutator mice, but mitochondrial dysfunction
in mitotic cells and tissues, such as in the blood progenitor cells
and intestinal epithelia, was shown to be more severe, likely leading to
the mortality of the mice (Kujoth et al., 2005). Others have identified
the ability to culture human mitochondrial ETC-deficient fibroblasts
in galactose or low glucose media to accentuate mitochondrial
dysfunction (Golubitzky et al., 2011; Kukat et al., 2011). These
conditions are known to shift cultured cells from a primarily
glycolytic metabolic state to a state with higher levels of oxidative
phosphorylation, stimulating mitochondrial biogenesis to maintain
adequate levels of cellular ATP (Elkalaf et al., 2013). When screening
10 candidate compounds for possible improvement of mitochondrial
function in patient ETC complex I-deficient fibroblasts, one group
identified AICAR as the most promising compound (Golubitzky
et al., 2011). Although the respiratory rate and mitochondrial
membrane potential was not increased by AICAR treatment in
that study, AICAR treatment increased mitochondrial biogenesis
and ATP levels, while improving cell growth and decreasing
ROS production.
Effects of AICAR on the respiratory rate

In the results presented here, an increase in the respiratory rate was
not observed in response to AICAR treatment of the immortalized
MEFs. Our results are consistent with many other groups that failed
to find an increase in the respiratory rate following AICAR treatment
(Golubitzky et al., 2011; Guigas et al., 2007; Spangenburg et al.,
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2013), even though AICAR treatment was shown to induce
mitochondrial biogenesis in rodent muscle (Suwa et al., 2015) and
human fibroblasts (Golubitzky et al., 2011). Instead, after 10 and
20 days of AICAR treatment in HGPUM, WT MEFs showed a
decreased respiratory rate. This decreased respiratory rate may have
been caused in part by AICAR-mediated upregulation of pyruvate
dehydrogenase kinase 4 (PDK-4) gene expression (Houten et al.,
2009), which leads to inhibition of the pyruvate dehydrogenase
complex, slowing the conversion of pyruvate to acetyl-CoA in the
mitochondrial matrix. AICAR treatment has also been shown to
induce many other non-specific effects on cellular metabolism
including inhibition of mitochondrial ETC complex I (Guigas et al.,
2007) and downregulation of the expression of several mitochondrial
ETC genes in a cell line dependent manner (Jose et al., 2011). AICAR
as well as the more specific AMPK inhibitor A-769662 have been
shown to inhibit oxygen consumption in cell culture, with A-769662
specifically inhibiting respiration in SV40 transformed MEFS
(Vincent et al., 2015). AICAR was also shown to inhibit glucose
consumption and lactate production by ∼50% in both WT and
AMPK-deficient MEFs (Vincent et al., 2015). These effects likely
prevented AICAR treatment from increasing respiration, even leading
to long term declines in the respiratory rate. An AICAR-mediated
decrease in the rate of glucose utilization was also likely responsible
for the preservation of ATP levels in the highly glycolytic mtDNA
mutator MEFs in LGPM after 48 h, when untreated cells showed
decreased ATP, likely from exhaustion of glucose and pyruvate from
the media.
Contrary to the sustained positive effects on muscle
mitochondrial biogenesis observed during AICAR treatment
(Suwa et al., 2015) and more similar to the temporal effects
observed here with the E1A immortalized MEFs, increased levels of
ETC transcripts were observed in mouse brain during the first week
of intraperitoneal injection of AICAR, while expression of these
ETC genes was decreased compared to vehicle-injected controls by
the day 14 of treatment (Guerrieri and van Praag, 2015). Future
studies should determine if long term AICAR treatment decreases
markers of mitochondrial mass such as mtDNA levels or citrate
synthase activity in specific tissues or cell types.
Effects of rapamycin on mitochondrial function

The molecular mechanisms behind the increase in respiratory rate of
WT MEFs, but not mtDNA mutator MEFs, following the 24 h
rapamycin treatment is unknown. However, one possibility is that
rapamycin induces a transient, selective increase in mitochondrial
uncoupling. mTOR inhibition has been shown to induce partial
uncoupling of mitochondrial oxidative phosphorylation in yeast
(Pan and Shadel, 2009), rat kidney (Simon et al., 2003; Sivertsson
and Friederich-Persson, 2013) and mouse adipose tissue (Polak
et al., 2008). Another possible mechanism for increased respiration
is increased mitochondrial biogenesis or decreased mitophagy.
Mitochondrial biogenesis was observed in adipose tissue following
mTOR inhibition (Deepa et al., 2013). A third possibility includes
rapamycin transiently inhibiting both mTORC1 and mTORC2 as
knockdown of the mTORC2 protein Rictor was associated with
increased oxidative metabolism (Schieke et al., 2006). The transient
increase in the respiratory rate in WT MEFs 24 h following
rapamycin addition in our study was somewhat surprising given that
other groups studying myotubes (Cunningham et al., 2007; Ye et al.,
2012), leukemic Jurkat T cells (Ramanathan and Schreiber, 2009;
Schieke et al., 2006) or T-cell lymphoma (Kittipongdaja et al.,
2015) did not find mTOR inhibition to stimulate the respiratory rate
and in most cases found a decreased rate of respiration.
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Pyruvate addiction in E1A immortalized MEFs

The mechanisms through which the E1A protein and autophagy
inducers facilitate pyruvate addiction and the mechanisms through
which autophagy inhibitors and AICAR decrease the rate of
pyruvate addiction are not yet known. Since the respiratory rate
slightly increased during the time period of pyruvate addiction, it
is hypothesized that treatments that facilitate pyruvate addiction
lead to a slow shift in energy production away from glycolysis
toward oxidative phosphorylation, resulting in more endogenously
produced pyruvate entering mitochondria for energy production
and less being used in the cytoplasm by lactate dehydrogenase to
maintain cytoplasmic NAD+ levels. So, during the time course of
pyruvate addiction, the E1A immortalized MEFs likely become
reliant on supplemental rather than endogenous pyruvate to
provide the cytoplasmic NAD+ levels required for normal cell
function and division. Since autophagy/mitophagy inducers
stimulate pyruvate addiction, it currently appears unlikely that
pyruvate addiction is associated with increased mitochondrial
mass, but future studies addressing possible relationships between
pyruvate addiction and mitochondrial biogenesis or mitophagy
may yield important insights into the molecular mechanisms of
these processes.
AICAR treatment has been shown to positively or negatively
affect the rate of autophagy depending upon the specific cell line or
primary cell type tested (Meley et al., 2006; Sanchez et al., 2012),
with negative effects mostly reported in hepatocytes and hepatic
stellate cells, where AICAR treatment increases mTOR signaling
and inhibits TGF-β signaling to inhibit autophagy (Chen et al.,
2017). When administered to MEFs, AICAR has been shown to

increase the abundance of several upstream markers of autophagy
(Lee et al., 2010; Qiang et al., 2013). However, results from a more
downstream functional assay of autophagy showed no change in the
rate of autophagy in the presence or absence of AICAR (Cheong
et al., 2011). AICAR administration has even been shown to
increase the pH of lysosomes (Meley et al., 2006), which would
decrease the rate of autophagy. Through this mechanism AICAR
may be inhibiting autophagy in E1A transformed MEFs to decrease
the rate of pyruvate addiction, but further studies are needed to
confirm this hypothesis.
To the best of our knowledge this is the first report of a cell line
becoming pyruvate addicted, while the study of glucose-addicted or
glutamine-addicted cell lines have yielded important insights into
human cancer cell metabolism (Wise and Thompson, 2010). Unlike
primary murine cells, primary human cells are not immortalized by
E1A expression alone and the E1A protein by itself does not
stimulate cell division (Li et al., 2004). This may be one reason that
pyruvate addiction has not been reported.
Future perspectives

Recent experiments with mtDNA mutator mice have yielded
potential therapies to slow mitochondrial dysfunction with aging.
Endurance exercise was shown to rescue the premature aging (Safdar
et al., 2011). However, CR, another common anti-aging therapy,
was unable to rescue the progeroid phenotype (Someya et al., 2017).
The inability of CR to extend lifespan in mtDNA mutator mice
suggests that increased mitochondrial ETC function or decreased
glycolytic metabolism, either of which can increase NAD+ levels,
may be required for CR to delay aging. Since rapamycin is a CR
mimetic (Nikolai et al., 2015) and CR did not extend the lifespan
of mtDNA mutator mice (Someya et al., 2017), rapamycin
treatment may not improve mitochondrial function in stem cells,
which likely limits the lifespan of these mice. However, rapamycin
was able to delay brain pathology in a mouse model of
mitochondrial complex I deficiency (Johnson et al., 2013).
Future studies should seek to determine the effects of rapamycin
on the lifespan of mtDNA mutator mice. In contrast to rapamycin,
AICAR has been described as an exercise mimetic (Narkar et al.,
2008). Therefore, we predict AICAR to have a better chance at
restoring mitochondrial function in stem cells to delay aging in these
mice. The exercise-induced rescue of mitochondrial function
in mtDNA mutator mice has been suggested to rely upon the
mitochondrial function of the p53 protein (Safdar et al., 2016b).
Therefore, future studies should focus on the identification of other
therapies that can mimic the effects of endurance exercise to
stimulate the translocation of p53 to the mitochondrial matrix to
increase mtDNA repair.
CONCLUSIONS

Evidence indicates that mitochondrial dysfunction in stem cells could
be a major contributor to aging and age-related diseases, underscoring
the need for mitotic cell models of mitochondrial dysfunction to
conveniently study this phenomenon. E1A immortalized mtDNA
mutator MEFs were created to fill this void. Under the standard HGM
conditions used, they did not show respiratory dysfunction, but did
show increased ROS production, both of which are contrary to results
obtained using the parental primary MEFs. However, upon pyruvate
addition to the media, immortalized WT MEFs showed greater
respiration than the immortalized mtDNA mutator MEFs. Rapamycin
treatment of WT MEFS resulted in a transient increase in respiration
that did not occur following treatment of mtDNA mutator MEFs. In
both mtDNA mutator and WT MEFs under high glucose conditions
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mTORC1 activity has been reported to have a significant positive
effect on mitochondrial function, increasing the resting respiratory
rate and oxidative capacity (Schieke et al., 2006). Rapamycin
treatment to inhibit mTORC1 activity has been shown to lower
mitochondrial membrane potential, respiratory rate, and ATP
synthesis in cultured cells (Schieke et al., 2006). Therefore it was
also somewhat surprising that rapamycin increased ATP levels
under several culture conditions in this study. However, the increase
in ATP levels upon rapamycin treatment is likely due to decreased
ATP consumption because of a decreased rate of protein synthesis
and other biosynthetic processes as the respiratory rate was generally
not changed when ATP levels increased. In addition, inhibition of
mTOR has generally been associated with decreased, not increased,
glycolytic activity (Sun et al., 2011). Further studies showed
that short term (12 h) inhibition of mTORC1 did not affect
mitochondrial function (Morita et al., 2013), but longer term
inhibition lowered the levels of the transcriptional regulator Yin
Yang 1 (YY1), resulting in downregulated expression of PGC-1α
and other regulators of mitochondrial function (Cunningham
et al., 2007). Knockdown of the mTORC1 protein Raptor
decreased the respiratory rate (Schieke et al., 2006). However, it
was found that the effects of rapamycin on the respiratory rate of
live mice depend upon the duration of rapamycin treatment.
Mice treated for 2 weeks showed a decreased respiratory rate,
while those treated for 20 weeks showed an increased rate of
respiration (Fang et al., 2013). Additionally, rapamycin treatment
transiently stimulated mitochondrial biogenesis in the heart of old
mice, with markers of mitochondrial biogenesis being upregulated
following 2 weeks of administration that returned to basal levels
by 10 weeks of administration (Chiao et al., 2016). Therefore, further
studies of the temporal effects of rapamycin on mitochondrial
function are warranted.
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MATERIALS AND METHODS
Generation of stable cell lines

MEFs were obtained from WT and homozygous POLGD257A/D257A
(POLGexo−) mitochondrial DNA mutator mouse decapitated
embryos (Kujoth et al., 2005) according to standard protocols and
frozen down (Lei, 2013). To generate stable cell lines, the MEFs were
thawed, plated and then stably transfected with a plasmid containing
the adenoviral E1A gene and a puromycin selectable marker using a
retroviral transfection system (Swift et al., 2001). E1A-induced
immortalization was used instead of spontaneous transformation to
preserve contact inhibition and monolayer growth and in an attempt to
preserve the function of genes in signaling pathways that commonly
mutate during spontaneous transformation. E1A immortalized MEFs
also formed well-defined colonies that were easier to count in toxicity
assays than spontaneously transformed MEFs. We, like others (Kukat
et al., 2011), found a higher rate of spontaneous transformation of the
mtDNA mutator MEFs compared to the WT MEFs (data not shown).
In rare instances following several months of culture some lines of
E1A immortalized MEFs would lose the ability to proliferate, flatten
and appear to undergo cellular senescence. In general cells appeared
healthy, but no stringent check was performed for cell line
contamination.
Cell culture

WT and mtDNA mutator MEFs were grown in either 96-well
plates or in 10 cm culture dishes using HyClone® Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with 10%
FBS, 30 µg/ml penicillin, 50 µg/ml streptomycin, and 2 mM
L-glutamine (Gibco; Thermo Fisher Scientific). For short term
studies, cells were grown using either high (4.5 g/l) or low (1 g/l)
glucose DMEM with or without 1 mM pyruvate for 24, 30 or 48 h.
For longitudinal studies, high glucose media with 1 mM pyruvate
and 50 µg/ml uridine (HGPUM) was used. Longitudinal (10, 20
and 29 days of treatment) studies were only performed in HGPUM
since MEFs cultured in low glucose media for the measurement of
oxygen consumption frequently did not survive the trypsinization
step prior to placing the cells in the Clark electrode chamber. The
media was changed every 2 days for cells grown for the 10, 20 and
29 day longitudinal studies. For the respiratory, ROS production
and ATP measurements, cells were treated with 1 mM AICAR or
with 10 nM rapamycin (LC Labs).
ATP assays

CellTiter-Glo (Promega, Madison, USA) ATP detection reagent
was used to determine the levels of ATP following a 10 min 22°C
incubation of cells with CellTiter-Glo reagent. CellTiter-Glo
reagent was combined with the cell suspension in a 1:1 ratio in a
96-well microplate and then shaken for 2 min. Luminescence was
read using a Biotek Synergy 2 microplate reader after the contents of
the 96-well plate were transferred to a white opaque bottom plate for
increased signal.

Oxygen consumption analysis

Cells were trypsinized from 10 cm dishes, the trypsin was
deactivated with culture media, and the cells were spun down and
resuspended in 1 ml of the appropriate fresh culture media. 350 µl of
the suspension was then placed into a Strathkelvin Mitocell
MT200A respiratory chamber with a Clark type electrode at 37°C
with a stir bar. The cellular respiratory rate was recorded for 4 min.
The middle 1 min was chosen for slope analysis. Oxygen
consumption was normalized to the total cell number in the
chamber. Cell counts were obtained using a hemocytometer. Both
the mtDNA mutator and WT MEFs greatly lost the ability to respire
upon trypsinization when cultured in low glucose culture medium
for 36 h or longer, and so time points for oxygen consumption
analysis were not obtained beyond 30 h when the MEFs were
cultured in this medium.
ROS measurements

2′,7′-dichlorodihydrofluorescein diacetate was used to detect
ROS production. Following hydrolysis of the acetate esters by
intracellular esterases, dichlorodihydrofluorescein is produced.
Dichlorodihydrofluorescein, when oxidized by ROS, becomes
the highly fluorescent compound dichlorofluorescein (DCF). A
2′,7′-dichlorodihydrofluorescein diacetate stock solution of 500 µM
was made up in 2% DMSO in PBS and the tube was wrapped in foil
to prevent exposure to light. Media was aspirated from the cells grown
in 96-well plates and the cells were washed once with 100 µl PBS. An
assay concentration of 50 µM was obtained by mixing 10 µl of the
stock solution with 90 µl of PBS and added to the monolayer of cells.
As a positive control, 0.5 µl of denatured 100% EtOH was added, as it
can greatly stimulate mitochondrial ROS production at electron
transport chain complexes I and III (Cunningham and Bailey, 2001).
The plate was incubated in the dark at 37°C for 30 min. The
fluorescence was then measured using a Biotek Synergy 2 microplate
reader with an excitation filter of 485/20 nm and emission filter of
528/15 nm. Values were normalized to the total amount of protein in
each well.
Protein assays

Cells were lysed and extracts were solubilized using modified RIPA
buffer without SDS. A determination of the protein concentration
was performed using the BCA protein assay (Pierce; Thermo
Fisher Scientific). Results were normalized using the protein
concentrations present for the assays.
Colony formation drug toxicity assays

The E1A immortalized MEFs were cultured in HGM consisting of
high glucose DMEM with the addition of 10% fetal bovine serum,
penicillin (100 U/ml), streptomycin (100 mg/ml) and L-glutamine
(2 mM). Three distinct mtDNA mutator MEF clones and three
distinct WT MEF clones were used for each experiment. 2000 cells
were placed in each well of a 6-well plate in HGM. For each 6-well
plate, five different concentrations of a drug were added 1 day after
the cells were plated, leaving one untreated well per plate. Drug
concentrations were doubled or tripled from one well to the next
depending upon the specific compound tested. Cells were grown for
8-10 days with one change of media. Then the culture media was
removed and the cells were washed twice with PBS. A 5% crystal
violet stock solution was made in 95% ethanol. 500 ml of a 0.5%
crystal violet staining solution was made by combining 50 ml of
the 5% crystal violet stock solution with 350 ml of methanol,
50 ml of 35% formaldehyde and 50 ml of deionized water. The
cells were fixed and stained for 10 min. Then the solution was
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short term AICAR treatment increased ROS levels and decreased ATP
levels, which in WT MEFs upon a longer duration of treatment
transitioned into decreased respiratory rates and ROS levels. Short
term AICAR treatment increased ATP levels when ATP levels were
low and generally decreased ATP levels when ATP levels were high.
The future use of E1A immortalized mtDNA mutator MEFs and other
cell lines containing active p53 should facilitate research into the role
of mtDNA mutations in stem cell aging and the mechanisms
responsible for the protective effects of endurance exercise on animals
with high levels of mtDNA mutations.
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Assays for determining compounds that alter the rate of
pyruvate addiction

The E1A immortalized MEFs were cultured in triplicate in 6-well
plates using HGPUM consisting of high glucose DMEM media
supplemented with 10% fetal bovine serum, penicillin (100 U/ml),
streptomycin (100 mg/ml), L-glutamine (2 mM), pyruvate (1 mM),
uridine (50 µg/ml) and a compound to be tested. Several autophagy
inhibitors including 3-methyladenine, bafilomycin A1, chloroquine
and ammonium chloride were toxic to the cells at the normal
doses used to inhibit autophagy, so concentrations were titrated
down to allow for long term viability. For example, a typical acute
treatment dose of 3-methyladenine is 5 mM, but for long term
treatment the immortalized MEFs could only survive at a
concentration of 4 mM. Typical acute treatment doses of
bafilomycin A1 for autophagy inhibition are 100 nM-1 µM, but
the immortalized MEFs could only survive long term at a
concentration of 1 nM. Typical acute treatment doses of
chloroquine range from 10-100 µM, but the immortalized MEFs
could only survive long term at a concentration of 6 µM. Typical
acute concentration doses of ammonium chloride used for
autophagy inhibition are 10-20 mM, but the immortalized MEFs
could only survive long term at a concentration of 5 mM.
We found AICAR to be toxic at a concentration of 3 mM, so we
used a 1 or 2 mM dose. We repeatedly found that following
rapamycin treatment for 8-12 days, the vast majority of the cell
population died suddenly, possibly due to delayed mTORC2
inhibition (Barlow et al., 2012), but we continued the long term
culture with the cells that were selected to resist this toxicity.
Every 3-4 days, cells would become confluent and so were
washed in PBS and trypsinized. Ninety per cent of the cells were
discarded and the remaining 10% of the cells returned to the same
well for continued culture. Every 9-12 days the 90% of the cells that
were normally discarded were counted using a Coulter Z1 Particle
Counter and 2000 cells from each well were seeded into a well in
each of two new 6-well plates. One 6-well plate was cultured using
HGPUM without drug treatment and the second 6-well plate was
cultured in the same media lacking pyruvate and uridine (HGM).
Cells were grown for 8-10 days with one change of media. Culture
media was removed and the cells were washed twice with PBS, and
fixed and stained with 0.5% crystal violet staining solution as
described above, de-stained with deionized water, and colonies
were counted manually. The percentage of the number of colonies
that formed in the absence of pyruvate and uridine (HGM)
compared to the number of colonies that formed in the presence
of pyruvate and uridine (HGPUM) was plotted each 9-12 days
for 3 weeks to 3 months depending upon the rate of the loss of
colony formation of the cells seeded in media lacking pyruvate and
uridine (HGM).
Statistical analysis

SigmaPlot version 11.0 was used for statistical analysis and graph
generation. For most of the analyses two-way ANOVA tests were
performed with genotype and treatment variables followed by

Fisher’s LSD post hoc means comparison. Unpaired t-tests were
used for the colony counting assays.
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